Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Blood Specimen Collection × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 10 Breast Neoplasms 8 Prostatic Neoplasms 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lung Diseases 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Vitamin D Deficiency 1 Vascular Diseases 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Diseases 1 Skin Neoplasms 1 Recurrence 1 Radiation Injuries 1 Pyruvate Kinase Deficiency of Red Cells 1 Pyloric Stenosis, Hypertrophic 1 Postoperative Complications 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1

Interventions

Specimen Handling 32 Biopsy 28 Magnetic Resonance Spectroscopy 24 pembrolizumab 23 Paclitaxel 15 Carboplatin 15 Nivolumab 12 Gemcitabine 12 Taxes 9 Cisplatin 9 trastuzumab deruxtecan 8 abemaciclib 7 Pemetrexed 7 Ipilimumab 7 130-nm albumin-bound paclitaxel 7 X-Rays 6 Radiosurgery 6 Irinotecan 6 Cyclophosphamide 6 Cetuximab 6 Trastuzumab 5 Fulvestrant 5 Fluorouracil 5 Drug Therapy 5 Bevacizumab 5 Albumin-Bound Paclitaxel 5 olaparib 4 fludarabine 4 durvalumab 4 Oxaliplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02133222 2026-03-31

AMMAM

Centre Hospitalier Universitaire de Nice

Phase NA Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡